New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
The quest to bring osteoarthritis to its knees

The quest to bring osteoarthritis to its knees

by Michael Allen,Horizon: The EU Research & Innovation MagazineCredit: Pixabay/CC0 Public DomainMillions of people in Europe and elsewhere suffer degeneration of joint cartilage in the knee,
Arthritis and Rheumatism February 18,2024
The quest to bring osteoarthritis to its knees

The quest to bring osteoarthritis to its knees

by Michael Allen,Horizon: The EU Research & Innovation MagazineCredit: Pixabay/CC0 Public DomainMillions of people in Europe and elsewhere suffer degeneration of joint cartilage in the knee,
Arthritis and Rheumatism February 18,2024
Arthritic hands: What works (and doesn't) to ease the pain?

Arthritic hands: What works (and doesn't) to ease the pain?

by Denise MannMillions of people who live with the pain and stiffness of arthritis in their hands get steroid or hyaluronic acid injections directly into their finger joints in the hopes of feeling be
Arthritis and Rheumatism February 18,2024
Arthritic hands: What works (and doesn't) to ease the pain?

Arthritic hands: What works (and doesn't) to ease the pain?

by Denise MannMillions of people who live with the pain and stiffness of arthritis in their hands get steroid or hyaluronic acid injections directly into their finger joints in the hopes of feeling be
Arthritis and Rheumatism February 18,2024
Methotrexate reduces pain in hand osteoarthritis with synovitis

Methotrexate reduces pain in hand osteoarthritis with synovitis

by Elana GotkineFor patients with hand osteoarthritis and synovitis, methotrexate has a potentially clinically meaningful effect on reducing pain, with no increase in adverse events, according to a st
Arthritis and Rheumatism February 18,2024
Methotrexate reduces pain in hand osteoarthritis with synovitis

Methotrexate reduces pain in hand osteoarthritis with synovitis

by Elana GotkineFor patients with hand osteoarthritis and synovitis, methotrexate has a potentially clinically meaningful effect on reducing pain, with no increase in adverse events, according to a st
Arthritis and Rheumatism February 18,2024
Ineffective painkillers are widely prescribed to patients with inflammatory arthritis in England, research finds

Ineffective painkillers are widely prescribed to patients with inflammatory arthritis in England, research finds

byKeele UniversityAnnual prevalence of all analgesic (A) and opioid strength (B) prescriptions in patients with inflammatory arthritis. AxSpA: axial spondyloarthritis; IA: inflammatory arthritis
Arthritis and Rheumatism February 18,2024
Ineffective painkillers are widely prescribed to patients with inflammatory arthritis in England, research finds

Ineffective painkillers are widely prescribed to patients with inflammatory arthritis in England, research finds

byKeele UniversityAnnual prevalence of all analgesic (A) and opioid strength (B) prescriptions in patients with inflammatory arthritis. AxSpA: axial spondyloarthritis; IA: inflammatory arthritis
Arthritis and Rheumatism February 18,2024
Contraceptive pills can lower the risk of rheumatoid arthritis, study finds

Contraceptive pills can lower the risk of rheumatoid arthritis, study finds

by Gustav Löfgren, Schwedischer Forschungsrat - The Swedish Research CouncilDirected Acyclic Graph (DAG) (12) on the association of exogenous hormones and Rheumatoid Arthritis (RA). For oral contracep
Arthritis and Rheumatism February 18,2024
Contraceptive pills can lower the risk of rheumatoid arthritis, study finds

Contraceptive pills can lower the risk of rheumatoid arthritis, study finds

by Gustav Löfgren, Schwedischer Forschungsrat - The Swedish Research CouncilDirected Acyclic Graph (DAG) (12) on the association of exogenous hormones and Rheumatoid Arthritis (RA). For oral contracep
Arthritis and Rheumatism February 18,2024
CBD as a painkiller: Efficacy not clinically proven

CBD as a painkiller: Efficacy not clinically proven

byMedical University of ViennaCredit: Pixabay/CC0 Public DomainCannabidiol (CBD) is marketed by some suppliers as a painkiller, e.g., for osteoarthritis of the knee. Animal experiments have show
Arthritis and Rheumatism February 18,2024
CBD as a painkiller: Efficacy not clinically proven

CBD as a painkiller: Efficacy not clinically proven

byMedical University of ViennaCredit: Pixabay/CC0 Public DomainCannabidiol (CBD) is marketed by some suppliers as a painkiller, e.g., for osteoarthritis of the knee. Animal experiments have show
Arthritis and Rheumatism February 18,2024
Study finds JAK inhibitors and tocilizumab effective in VEXAS syndrome

Study finds JAK inhibitors and tocilizumab effective in VEXAS syndrome

byAmerican College of RheumatologyCredit: CC0 Public DomainNew research at ACR Convergence 2023, the American College of Rheumatology's (ACR) annual meeting, found that JAK inhibitors (JAKi)
Immunology & Rheumatology February 18,2024
Study finds JAK inhibitors and tocilizumab effective in VEXAS syndrome

Study finds JAK inhibitors and tocilizumab effective in VEXAS syndrome

byAmerican College of RheumatologyCredit: CC0 Public DomainNew research at ACR Convergence 2023, the American College of Rheumatology's (ACR) annual meeting, found that JAK inhibitors (JAKi)
Immunology & Rheumatology February 18,2024
21.2 percent of US adults had diagnosed arthritis from 2019 to 2021

21.2 percent of US adults had diagnosed arthritis from 2019 to 2021

by Elana GotkineAn estimated 21.2 percent of U.S. adults had diagnosed arthritis from 2019 to 2021, with most cases among adults aged 45 years and older, according to research published in the Oct. 13
Immunology & Rheumatology February 18,2024
21.2 percent of US adults had diagnosed arthritis from 2019 to 2021

21.2 percent of US adults had diagnosed arthritis from 2019 to 2021

by Elana GotkineAn estimated 21.2 percent of U.S. adults had diagnosed arthritis from 2019 to 2021, with most cases among adults aged 45 years and older, according to research published in the Oct. 13
Immunology & Rheumatology February 18,2024
Does this cause cancer? How scientists determine whether a chemical is carcinogenic

Does this cause cancer? How scientists determine whether a chemical is carcinogenic

by Brad Reisfeld,The ConversationPeople areexposed to numerous chemicalsthroughout their lifetimes. These chemicals can be from the air, foods, personal care items, household product
Oncology February 18,2024
Does this cause cancer? How scientists determine whether a chemical is carcinogenic

Does this cause cancer? How scientists determine whether a chemical is carcinogenic

by Brad Reisfeld,The ConversationPeople areexposed to numerous chemicalsthroughout their lifetimes. These chemicals can be from the air, foods, personal care items, household product
Oncology February 18,2024
Researchers image live drug response and resistant 'pockets' in pancreatic cancer

Researchers image live drug response and resistant 'pockets' in pancreatic cancer

by Garvan Institute of Medical ResearchSchematic of spatiotemporal AKT activity mapping in several organ systems in vivo.Optical window–mediated intravital assessment of metabolic and malignancy-
Oncology February 18,2024
Researchers image live drug response and resistant 'pockets' in pancreatic cancer

Researchers image live drug response and resistant 'pockets' in pancreatic cancer

by Garvan Institute of Medical ResearchSchematic of spatiotemporal AKT activity mapping in several organ systems in vivo.Optical window–mediated intravital assessment of metabolic and malignancy-
Oncology February 18,2024
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com